Publications by authors named "Armin Gerger"

Claim this Profile
P
Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE.
Karin Potthoff, Jens Uhlig, Lutz Jacobasch, Lothar Müller, Marcel Reiser, Armin Gerger

Int J Cancer· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of urinary cfDNA workflows for the molecular profiling of malignant disease.
Anna Eberhard, Tina Moser, Leandra Ziegler, Georgios Vlachos, Martina Loibner, Armin Gerger

iScience· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology.
Damian T Rieke, Michael Bitzer, Annalen Bleckmann, Alexander Desuki, Thomas Ernst, Armin Gerger

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study.
Sebastian Stintzing, Susanne Klein-Scory, Ludwig Fischer von Weikersthal, Martin Fuchs, Florian Kaiser, Armin Gerger

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors.
Florian Moik, Jakob M Riedl, Dominik Barth, Franziska Berton, Michael Fink, Armin Gerger

JACC CardioOncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view.
Jakob M Riedl, Florian Moik, Tamara Esterl, Sarah M Kostmann, Armin Gerger

Virchows Arch· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
Dominik A Barth, Florian Moik, Sarah Steinlechner, Florian Posch, Marie-Christina Mayer, Armin Gerger

J Immunother Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse.
Katja Sallinger, Michael Gruber, Christin-Therese Müller, Lilli Bonstingl, Elisabeth Pritz, Armin Gerger

J Transl Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statement.
Hossein Taghizadeh, Angela Djanani, Wolfgang Eisterer, Armin Gerger, Birgit Gruenberger

Front Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy - An Update.
Ewald Wöll, Arno Amann, Wolfgang Eisterer, Armin Gerger, Birgit Grünberger

Anticancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Angelika Terbuch, Gudrun Walser, Michael Stotz, Armin Gerger, Florian Posch

Clin Genitourin Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Analysis of Treatment Pathways in Patients With BRAF-mutant Metastatic Colorectal Carcinoma - MORSE.
Armin Gerger, Wolfgang Eisterer, Stefan Fuxius, Sara Bastian, Dieter Koeberle

Anticancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Dominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg, Thomas Bauernhofer, Gudrun Absenger, Armin Gerger

Cancer Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Franziska Maisel, Maria A Smolle, Stefanie Mollnar, Jakob M Riedl, Dominik A Barth, Armin Gerger

Clin Genitourin Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Jakob M Riedl, Esther Schwarzenbacher, Florian Moik, Lena Horvath, Antonia Gantschnigg, Armin Gerger

Thromb Haemost· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Dominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, Thomas Bauernhofer, Gudrun Absenger, Armin Gerger

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response.
Felix Prinz, Katharina Jonas, Amar Balihodzic, Christiane Klec, Andreas Reicher, Armin Gerger

RNA Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Moritz Müller, Florian Posch, Dominik Kiem, Dominik Barth, Lena Horvath, Armin Gerger

Ther Adv Med Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study.
Maria A Smolle, Laurin Herbsthofer, Barbara Granegger, Mark Goda, Iva Brcic, Armin Gerger

Br J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.
Florian Posch, Felix Prinz, Amar Balihodzic, Christian Mayr, Tobias Kiesslich, Armin Gerger

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Jakob M Riedl, Florian Posch, Lena Horvath, Antonia Gantschnigg, Felix Renneberg, Armin Gerger

Eur J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of soft-tissue sarcomas with FoundationOne Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Susanne Scheipl, Iva Brcic, Tina Moser, Stefan Fischerauer, Jakob Riedl, Armin Gerger

Ther Adv Med Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Aging and Immunotherapy in Cancer.
Melanie Kaiser, Maria Donatella Semeraro, Markus Herrmann, Gudrun Absenger, Armin Gerger

Int J Mol Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma.
Maria A Smolle, Laurin Herbsthofer, Mark Goda, Barbara Granegger, Iva Brcic, Armin Gerger

Oncoimmunology· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Jakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, Lukas Scheipner, Florian Posch, Armin Gerger

Ther Adv Med Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis